| Income Statement |
| Operating Expenses | 8.64M |
|
| Research and Development Expense | 6.97M |
| Selling, General and Administrative Expense | 1.67M |
| Operating Income | -8.64M |
| Net Income | -8.24M |
| Net Income Common Stock | -8.24M |
| Net Income Common Stock (USD) | -8.24M |
| Consolidated Income | -8.24M |
| Earnings per Basic Share | -1.26 |
| Earnings per Basic Share (USD) | -1.26 |
| Earnings per Diluted Share | -1.26 |
| Earning Before Interest & Taxes (EBIT) | -8.24M |
| Earning Before Interest & Taxes (USD) | -8.24M |
| Weighted Average Shares | 6.53M |
| Weighted Average Shares Diluted | 6.53M |
| Balance Sheet |
| Cash and Equivalents | 63.81M |
| Cash and Equivalents (USD) | 63.81M |
| Investments | 33.75K |
| Investments Current | 33.75K |
| Current Assets | 65.61M |
| Total Assets | 67.41M |
| Current Liabilities | 6.61M |
| Total Liabilities | 6.69M |
| Accumulated Retained Earnings (Deficit) | -138.65M |
| Accumulated Other Comprehensive Income | -371.18K |
| Shareholders Equity | 60.72M |
| Shareholders Equity (USD) | 60.72M |
| Assets Non-Current | 1.80M |
| Liabilities Non-Current | 79.38K |
| Trade and Non-Trade Payables | 1.72M |
| Cash Flow |
| Net Cash Flow from Financing | 70.08M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 57.70M |
| Issuance (Purchase) of Equity Shares | 70.08M |
| Net Cash Flow from Operations | -12.38M |
| Share Based Compensation | 189.43K |